
Strantas 250mg Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Fulvestrant (250mg)
Overview Strantas 250mg Injection
Tamoxifen 250mg Injection is an anti-estrogen medication employed in postmenopausal women with breast cancer. Its mechanism involves estrogen level modulation, thereby inhibiting cancerous cell proliferation. Administered intramuscularly under medical guidance, the dosage and frequency are determined by the treating physician based on individual needs and response. Treatment duration adheres to the prescribed regimen. Common adverse effects encompass injection site inflammation, headache, nausea, vomiting, and allergic responses. Significant or persistent side effects warrant immediate medical attention; management strategies may be available. Prior to commencing treatment, disclose any history of hepatic or renal impairment, bleeding disorders, anticoagulant use, or concurrent medications to your physician. Furthermore, inform your doctor of pregnancy, pregnancy plans, or breastfeeding.
Uses of Strantas 250mg Injection
Malignant breast tumor
Major Benefits of Strantas 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Strantas 250mg Injection:
- Headache
- Vomiting
- Weakness
- Allergic reaction
- Nausea
- Injection site reaction
- Urinary tract infection
- Diarrhea
How to use Strantas 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Strantas 250mg Injection works:
Strantas 250mg Injection inhibits estrogen's effects on breast cancer cells, potentially halting or reducing the growth of estrogen-dependent tumors.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Strantas 250mg Injection and alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Strantas 250mg Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Administering Strantas 250mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingSAFE
Driving ability is typically unaffected by a 250mg Strantas injection.
KidneyCAUTION
For individuals with severe kidney impairment, administering Strantas 250mg Injection requires careful consideration. A modified dosage of Strantas 250mg Injection may be necessary; physician consultation is advised. Data regarding Strantas 250mg Injection use in such patients is limited. Dosage alteration is not suggested for those with mild or moderate kidney disease.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when administering Strantas 250mg Injection. Dosage modification of Strantas 250mg Injection may be necessary. A physician's consultation is advised.
What if you forget to take Strantas 250mg Injection :
Omit one dose of Strantas 250mg Injection? Seek your physician's advice.
Facts to Know About Strantas 250mg Injection
Label | Value |
---|---|
Chemical Classification | Estrogen Derivatives |
Developing Habits | No. |
Treatment Category | Cancer Medications |
Actions | Estrogen receptor blocker |